The 10-year period after the marketing authorisation of an orphan medicine when similar medicines for the same indication cannot be placed on the market.
More information can be found under 'Marketing authorisation and market exclusivity'.
The 10-year period after the marketing authorisation of an orphan medicine when similar medicines for the same indication cannot be placed on the market.
More information can be found under 'Marketing authorisation and market exclusivity'.